Imaging of hepatic cirrhosis

Radiology

Volumn 202, Issue 1, 1997, Pages 1-16

  Brown, Jeffrey J ^a   Naylor, Michael J ^a   Yagan, Neda ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Liver, cirrhosis; State of art reviews

Indexed keywords

ALCOHOL; COLCHICINE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM CHELATE; GALLIUM CITRATE GA 67; IODINATED POPPYSEED OIL; MACROSALB TC 99M; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; RADIOPHARMACEUTICAL AGENT; SUPERPARAMAGNETIC IRON OXIDE; TECHNETIUM SULFUR COLLOID TC 99M;

ALCOHOL LIVER CIRRHOSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE CLASSIFICATION; ECHOGRAPHY; ESOPHAGUS VARICES BLEEDING; HISTOPATHOLOGY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NODULE; LIVER SCINTISCANNING; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTOSYSTEMIC ANASTOMOSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031012082     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.202.1.8988182     Document Type: Review

References (142)

1. Laënnec RTH. Traité de l'auscultation médicale. Paris, France: Chaude, 1826; 196.
2. Podolsky DK, Isselbacher KJ. Alcohol-related liver disease and cirrhosis. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's principles of internal medicine. 13th ed. New York, NY: McGraw-Hill, 1994; 1483-1495.
3. Conn HO, Atterbury CE. Cirrhosis. In: Schiff L, Schiff ER, eds. Diseases of the liver. 7th ed. Philadelphia, Pa: Lippincott, 1993; 875-934.
4. Cohen S, Soloway RD, eds. Chronic active liver disease. New York, NY: Churchill Livingstone, 1982.
5. Alter HJ. The hepatitis C virus and its relationship to the clinical spectrum of NANB hepatitis. J Gastroenterol Hepatol 1990; 5(suppl 1):78-94.
6. Genesca J, Esteban JI, Alter HJ. Blood-borne non-A, non-B hepatitis: hepatitis C. Semin Liver Dis 1991; 11:147-164.
7. Davis GL. Recombinant alpha-interferon treatment of non-A, and non-B (type C) hepatitis: review of studies and recommendations for treatment. J Hepatol 1990; 11(suppl 1):72-77.
8. Orrego H, Medline A, Blendis LM, Rankin JG, Kreaden DA. Collagenisation of the Disse space in alcoholic liver disease. Gut 1979; 20:673-679.
9. Mallory FB. Cirrhosis of the liver: five different types of lesions from which it may arise. Johns Hopkins Med J 1911; 22: 69-75.
10. Leevy CM. Disease of the liver and biliary tract: standardization of nomenclature, diagnostic criteria and diagnostic methodology. In: Fogarty International Center Proceedings, no. 22. Department of Health, Education and Welfare publication no. (NIH) 76-225. Washington, DC: Government Printing Office, 1976.
11. Steiner PE. Precision in the classification of cirrhosis of the liver. Am J Pathol 1960; 37:21-47.
12. MacSween RNM, Sumithran E. Histopathology of primary biliary cirrhosis. Semin Liver Dis 1981; 1:282-292.
13. Portmann B, Popper H, Neuberger J, et al. Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients. Gastroenterology 1985; 88:1777-1790.
14. Furuya K, Nakamura M, Yamamoto Y, Togei K, Atsuka H. Macroregenerative nodule of the liver: a clinical pathologic study of 345 autopsy cases of chronic liver disease. Cancer 1988; 61:99-105.
15. Kondo F, Ebara M, Sugiura N, et al. Histological features and clinical course of large regenerative nodules: evaluation of their precancerous potentiality. Hepatology 1990; 12:592-598.
16. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22:983-993.
17. Ferrell LD, Crawford JM, Dhillon AP, Scheuer PJ, Nakanuma Y. Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol 1993; 17:1113-1123.
18. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. I. N Engl J Med 1989; 321:1014-1022.
19. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. II. N Engl J Med 1989; 321:1092-1099.
20. Miller-Catchpole R. Transjugular intrahepatic portosystemic shunt (TIPS): diagnostic and therapeutic technology assessment (DATTA). JAMA 1995; 273:1824-1830.
21. Rössle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330:165-171.
22. Rogers CG Jr, Paolini RM, O'Leary JP. Intrahepatic vascular shunting for portal hypertension: early experience with the transjugular intrahepatic portosystemic shunt. Am Surg 1994; 60:114-117.
23. Helton WS, Belshaw A, Althaus S, Park S, Coldwell D, Johansen K. Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg 1993; 165:566-571.
24. LaBerge JM, Somberg KA, Lake JR, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995; 108:1143-1151.
25. Di Lelio A, Cestari C, Lomazzi A, Beretta L. Cirrhosis: diagnosis with sonographic study of the liver surface. Radiology 1989; 172:389-392.
26. Giorgio A, Ambroso P, Lettieri G, et al. Cirrhosis: value of caudate to right lobe ratio in diagnosis with ultrasound. Radiology 1986; 161:443-445.
27. Hess CF, Schmiedl U, Coelbel G, Knecht R, Kurtz B. Diagnosis of liver cirrhosis with US: receiver-operating characteristic analysis of multidimensional caudate lobe indexes. Radiology 1989; 171:349-351.
28. Goyal AK, Pokharna DS, Sharma SK. Ultrasonic diagnosis of cirrhosis: reference to quantitative measurements of hepatic dimensions. Gastrointest Radiol 1990; 15:32-34.
29. Harbin WP, Robert NJ, Ferrucci JT Jr. Diagnosis of cirrhosis based on regional changes in hepatic morphology. Radiology 1980; 135:273-283.
30. Ralls PW. Color Doppler sonography of the hepatic artery and portal venous system. AJR 1990; 155:522-526.
31. Wing VW, Laing FC, Jeffrey RB, Guyon J. Sonographic differentiation of enlarged hepatic arteries from dilated intrahepatic bile ducts. AJR 1985; 145:57-61.
32. Middleton WD. The liver. In: Kurtz AB, Middleton WD, eds. Ultrasound: the requisites. St Louis, Mo: Mosby-Year Book, 1996; 3-34.
33. Tessler FN, Gehring BJ, Gomes AS, et al. Diagnosis of portal vein thrombosis: value of color Doppler imaging. AJR 1991; 157: 293-296.
34. Grant EG, Schiller VL, Millener P, et al. Color Doppler imaging of the hepatic vasculature. AJR 1992; 159:943-950.
35. Dodd GD III, Memel DS, Baron RL, Eichner L, Santiguida LA. Portal vein thrombosis in patients with cirrhosis: does sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus? AJR 1995; 165:573-577.
36. Dodd GD III, Carr BI. Percutaneous biopsy of portal vein thrombus: a new staging technique for hepatocellular carcinoma. AJR 1993; 161:229-233.
37. Subramanyan BR, Balthasar EJ, Madamba MR, et al. Sonography of portosystemic venous collaterals in portal hypertension. Radiology 1983; 146:161-166.
38. Lafortune M, Constantin A, Breton G, Legare AG, Lavoie P. The recanalized umbilical vein in portal hypertension: a myth. AJR 1985; 144:549-553.
39. Gibson RN, Gibson PR, Donlan JD, Clunie DA. Identification of a patent periumbilical vein by using Doppler sonography: importance in the diagnosis of portal hypertension. AJR 1989; 153:513-516.
40. Morin C, Lafortune M, Pomier G, Robin M, Breton G. Patent paraumbilical vein: anatomic and hemodynamic variants and their clinical importance. Radiology 1992; 185:253-256.
41. Jahnke EJ, Palmer ED, Brick IB. The Cruveilhier-Baumgarten syndrome: a review and report of four cases, three treated by direct portocaval shunt. Ann Surg 1954; 140:44-55.
42. Wachsberg RH, Simmons MZ. Coronary vein diameter and flow direction in patients with portal hypertension: evaluation with Duplex sonography and correlation with variceal bleeding. AJR 1994; 162: 637-641.
43. Bolondi L, Li Bassi S, Gaiani S, et al. Liver cirrhosis: changes of Doppler waveform of hepatic veins. Radiology 1991; 178:513-516.
44. Colli A, Cocciolo M, Riva, et al. Abnormalities of Doppler waveform of the hepatic veins in patients with chronic liver disease: correlation with histologic findings. AJR 1994; 162:833-837.
45. Sheu JC, Sung JL, Chen DS, et al. Ultrasonography of small hepatic tumors using high-resolution linear-array real-time instruments. Radiology 1984; 150:797-802.
46. Sheu JC, Sung JL, Chen DS, et al. Early detection of hepatocellular carcinoma by real-time ultrasonography: a prospective study. Cancer 1985; 56:660-666.
47. Tanaka S, Kitamura T, Nakanishi K, et al. Effectiveness of periodic check up by ultrasonography for the early diagnosis of hepatocellular carcinoma. Cancer 1990; 66:2210-2214.
48. Takayasu K, Moriyama N, Muramatsu Y, et al. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. AJR 1990; 155: 49-54.
49. Dodd GD III, Miller WJ, Baron RL, Skolnick ML, Campbell WL. Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening tool. AJR 1992; 159:727-733.
50. Taourel PG, Pageaux GP, Coste V, et al. Small hepatocellular carcinoma in patients undergoing liver transplantation: detection with CT after injection of iodized oil. Radiology 1995; 197:377-380.
51. Tanaka S, Kitamura T, Imaoka S, et al. Hepatocellular carcinoma: sonographic and histologic correlation. AJR 1983; 140: 701-707.
52. Ebara M, Ohto M, Shinagawa T, et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. Gastroenterology 1986; 90:289-298.
53. Wernecke K, Vassallo P, Bick U, Diederich S, Peters PE. The distinction between benign and malignant liver tumors on sonography: value of a hypoechoic halo. AJR 1992; 159:1005-1009.
54. Taylor KJW, Ramos I, Morse SS, Fortune KL, Hammers L, Taylor CR. Focal liver masses: differential diagnosis with pulsed Doppler US. Radiology 1987; 164:643-647.
55. Dock W, Grabenwöger F, Metz V, Eibenberger K, Farrés MT. Tumor vascularization: assessment with duplex sonography. Radiology 1991; 181:241-244.
56. Tanaka S, Kitamura T, Fujita M, Nakanishi K, Okuda S. Color Doppler flow imaging of liver tumors. AJR 1990; 154:509-514.
57. Machi J, Sigel B, Zaren HA, Kurohiji T, Yamashita Y. Operative ultrasonography during hepatobiliary and pancreatic surgery. World J Surg 1993; 17:640-646.
58. Murakami T, Nakamura H, Hori S, et al. CT and MRI of cirrhotic regenerating nodules in hepatic cirrhosis. J Comput Assist Tomgr 1992; 16:578-582.
59. Chezmar JL, Nelson RC, Malko JA, Bernardino ME. Hepatic iron overload: diagnosis and quantification by non-invasive imaging. Gastrointest Radiol 1990; 15:27-31.
60. Dixon AK, Walshe JM. Computed tomography of the liver in Wilson disease. J Comput Assist Tomogr 1984; 8:46-49.
61. Murakami T, Baron RL, Peterson MS. Liver necrosis and regeneration after fulminant hepatitis: pathologic correlation with CT and MR findings. Radiology 1996; 198:239-242.
62. Baron RL, Oliver JH III, Dodd GD III, Nalesnik M, Holbert BL, Carr B. Hepatocelluldr carcinoma: evaluation with biphasic contrast-enhanced, helical CT. Radiology 1996; 199:505-511.
63. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 1993; 188:405-411.
64. Miles KA, McPherson SJ, Hayball MP. Transient splenic inhomogeneity with contrast-enhanced CT: mechanism and effect of liver disease. Radiology 1995; 194: 91-95.
65. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 1991; 178:493-497.
66. Conway JC, Popp JA, Thurman RG. Microcirculation of hepatic nodules from diethylnitrosamine-treated rats. Cancer Res 1985; 45:3620-3625.
67. Young ST, Paulson EK, Washington K, Gulliver DJ, Vredenburgh JJ, Baker ME. CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. AJR 1994; 163:1385-1388.
68. Weinbren K, Mutum SS. Pathological aspects of diffuse nodular hyperplasia of the liver. J Pathol 1984; 143:81-92.
69. Yamashita Y, Takahashi M, Baba Y, et al. Hepatocellular carcinoma with or without cirrhosis: a comparison of CT and angiographic presentations in the United States and Japan. Abdom Imaging 1993; 18:168-175.
70. Freeny PC, Baron RL, Teefey SA. Hepatocellular carcinoma: reduced frequency of typical findings with dynamic contrast-enhanced CT in a non-Asian population. Radiology 1992; 182:143-148.
71. Itai Y, Araki T, Furui S, Tasaka A. Differential diagnosis of hepatic masses on computed tomography, with particular reference to hepatocellular carcinoma. J Comput Assist Tomogr 1991; 5:834-842.
72. Imaeda T, Kanematsu M, Mochizuki R, Goto H, Saji S, Shimokawa K. Extracapsular invasion of small hepatocellular carcinoma: MR and CT findings. J Comput Assist Tomogr 1994; 18:755-760.
73. Nakashima O. Pathomorphological study on early hepatocellular carcinoma: a study of capsule and septum formation. Acta Hepatol Jpn 1989; 30:28-34.
74. Hirooka N, Iwasaki I. Histopathological study of small liver cancer with reference to its structure and growth pattern. Acta Hepatol Jpn 1984; 25:384-392.
75. Miller WJ, Baron RL, Dodd GD III, Federle MP. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 1994; 193:645-650.
76. Oliver JH III, Baron RL, Dodd GD III, Peterson MS, Carr BI. Does advanced cirrhosis with portosystemic shunting affect the value of CT arterial portography in the evaluation of the liver. AJR 1995; 164. 333-337.
77. Peterson MS, Baron RL, Dodd GD III, et al. Imaging-pathologic correlation of hepatic parenchymal perfusion defects detected by CT arterial portography. Radiology 1992; 185:149-155.
78. Kanematsu M, Oliver JH III, Baron RL, Federle MP, Carr BI. Detecting hepato-cellular carcinoma: the role of biphasic contrast-enhanced CT versus CT during arterial portography (abstr). Radiology 1995; 197(P):138.
79. Ohashi I, Hanafusa K, Yoshida T. Small hepatocellular carcinomas: two-phase incremental CT in detection and evaluation. Radiology 1993; 189:851-855.
80. Merine D, Takayasu K, Wakao F. Detection of hepatocellular carcinoma: comparison of CT during arterial portography with CT after intraarterial injection of iodized oil. Radiology 1990; 175:707-710.
81. Baron RL, Campbell WL, Dodd GD III. Peribiliary cysts associated with severe liver disease: imaging-pathologic correlation. AJR 1994; 162:631-636.
82. Wanless IR, Zahradnik J, Heathcote EJ. Hepatic cysts of periductal gland origin presenting as obstructive jaundice. Gastroenterology 1987; 93:894-898.
83. Chin NW, Chapman I, Jimenez FA. Mucinous hamartoma of the biliary duct system causing obstructive jaundice. Hum Pathol 1988; 19:112-114.
84. Ohtomo K, Baron RL, Dodd DG III, et al. Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT. Radiology 1993; 188:31-35.
85. Butts K, Riederer SJ, Ehman RL, Felmlee JP, Grimm RC. Echo-planar imaging of the liver with a standard MR imaging system. Radiology 1993; 189:259-264.
86. Reimer P, Ladebeck R, Rummeny EJ, et al. Initial feasibility studies using single-shot EPI for the detection of focal liver lesions. Magn Reson Med 1994; 32:733-737.
87. Oshio K, Feinberg DA. GRASE (gradient- and spin-echo) imaging: a novel fast MRI technique. Magn Reson Med 1991; 20:344-349.
88. Marti-Bonmatí L, Talens A, del Olmo J, et al. Chronic hepatitis and cirrhosis: evaluation by means of MR imaging with histologic correlation. Radiology 1993; 188:37-43.
89. Semelka RC, Willms AB, Brown MA, Brown ED, Finn JP. Comparison of breath-hold T1-weighted MR sequences for imaging of the liver. JMRI 1994; 4:759-765.
90. Brown JJ, Borrello JA, Raza HS, et al. Dynamic contrast-enhanced MR imaging of the liver: parenchymal enhancement patterns. Magn Reson Imaging 1995; 13:1-8.
91. Kadoya M, Osamu M, Kitagawa K, et al. Segmental iron deposition in the liver due to decreased intrahepatic portal perfusion: findings at MR imaging. Radiology 1994; 193:671-676.
92. Mitchell DG, Kim I, Chang TS, et al. Fatty liver: chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol 1991; 26:1041-1052.
93. Levenson H, Greensite F, Hoefs J, et al. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy. AJR 1991; 156:307-312.
94. Martín J, Sentís M, Zidan A, et al. Fatty metamorphosis of hepatocellular carcinoma: detection with chemical shift gradient-echo MR imaging. Radiology 1995; 195:125-130.
95. Edelman RR, Zhao B, Liu C, et al. MR angiography and dynamic flow evaluation of the portal venous system. AJR 1989; 153:755-760.
96. Johnson CD, Ehman RL, Rakela J, Ilstrup DM. MR angiography in portal hypertension: detection of varices and imaging techniques. J Comput Assist Tomogr 1991; 15:578-584.
97. Finn JP, Kane RA, Edelman RR, et al. Imaging of the portal venous system in patients with cirrhosis: MR angiography vs duplex Doppler sonography. AJR 1993; 161:989-994.
98. Burkart DJ, Johnson CD, Morton MJ, Ehman RL. Phase-contrast cine MR angiography in chronic liver disease. Radiology 1993; 187: 407-412.
99. Nghiem HV, Freeny PC, Winter TC III, Mack LA, Yuan C. Phase-contrast MR angiography of the portal venous system: preoperative findings in liver transplant recipients. AJR 1994; 163:445-450.
100. Silverman JM, Podesta L, Villamil F, et al. Portal vein patency in candidates for liver transplantation: MR angiography analysis. Radiology 1995; 197:147-152.
101. Edelman RR, Mattle HP, Kleefield J, Silver MS. Quantification of blood flow with dynamic MR imaging and presaturation bolus tracking. Radiology 1989; 171:551-556.
102. Burkart DJ, Johnson CD, Ehman RL, Weaver AL, Ilstrup DM. Evaluation of portal venous hypertension with cine phase-contrast MR flow measurements: high association of hyperdynamic portal flow with variceal hemorrhage. Radiology 1993; 188:643-648.
103. Debatin JF, Marincek B, Romanowski B, Wildermuth S, Meyenberger C, Schöpke W. Azygos blood flow: CINE-PC MR quantitation in patients with portal hypertension before and after TIPSS (abstr). In: Proceedings of the Society of Magnetic Resonance and the European Society for Magnetic Resonance in Medicine and Biology 1995. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1995; 74.
104. Wu MT, Pan HB, Chen C, et al. Azygos blood flow in cirrhosis: measurement with MR imaging and correlation with variceal hemorrhage. Radiology 1996; 198:457-462.
105. Murakami T, Kuroda C, Marukawa T, et al. Regenerating nodules in hepatic cirrhosis: MR findings with pathologic correlation. AJR 1990; 155:1227-1231.
106. Taylor AJ, Carmody TJ, Quiroz FA, et al. Focal masses in cirrhotic liver: CT and MR imaging features. AJR 1994; 163:857-862.
107. Ohtomo K, Itai Y, Ohtomo Y, Shiga J, Iio M. Regenerating nodules of liver cirrhosis: MR imaging with pathologic correlation. AJR 1990; 154:505-507.
108. Terada T, Nakanuma Y. Survey of iron-accumulative macroregenerative nodules in cirrhotic livers. Hepatology 1989; 10: 851-854.
109. Sagoh T, Itoh K, Togashi K, et al. Gamna-Gandy bodies of the spleen: evaluation with MR imaging. Radiology 1989; 172: 685-687.
110. Matsui O, Kadoya M, Kameyama T, et al. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging. Radiology 1989; 173:123-126.
111. Lencioni R, Caramella D, Moretti M, et al. Small mass lesions in liver cirrhosis: differentiation of hepatocellular carcinoma and adenomatous hyperplasia with dynamic gadolinium-enhanced MR imaging (abstr). In: Proceedings of the Society of Magnetic Resonance and the European Society for Magnetic Resonance in Medicine and Biology 1995. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1995; 410.
112. Rummeny E, Weissleder R, Stark DD, et al. Primary liver tumors: diagnosis by MR imaging. AJR 1989; 152:63-72.
113. Ebara M, Ohto M, Waranabe Y, et al. Diagnosis of small hepatocellular carcinoma: correlation of MR imaging and tumor histologic studies. Radiology 1986; 159:371-377.
114. Matsui O, Kadoya M, Yoshikawa J, et al. Aberrant gastric venous drainage in cirrhotic livers: imaging findings in focal areas of liver parenchyma. Radiology 1995; 197:345-349.
115. Ebara M, Watanabe S, Kita K, et al. MR imaging of small hepatocellular carcinoma: effect of intratumoral copper content on signal intensity. Radiology 1991; 180:617-621.
116. Hsu HC, Sheu JC, Lin YH, et al. Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan: a comparison with resected large HCC. Cancer 1985; 56:672-680.
117. Terada T, Kadoya M, Nakanuma Y, Matsui O. Iron-accumulating adenomatous hyperplastic nodule with malignant foci in the cirrhotic liver. Cancer 1990; 65:1994-2000.
118. Mitchell DG, Rubin R, Siegelman E, et al. Hepatocellular carcinoma within siderotic regenerative nodules: the "nodule-within-nodule" sign on MR images. Radiology 1991; 178:101-103.
119. Yamashita Y, Mitsuzake K, Tang Y, et al. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 1996; 200:79-84.
120. Mitchell DG. Focal manifestations of diffuse liver disease at MR imaging. Radiology 1992; 185:1-11.
121. Ohtomo K, Baron RL, Dodd GD III, Federle MP, Ohtomo Y, Confer SR. Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. Radiology 1993; 189:871-874.
122. Bernardino ME, Young SW, Lee JK, Weinreb JC. Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity. Radiology 1992; 183:53-58.
123. Weissleder R. Liver MR imaging with iron oxides: toward consensus and clinical practice. Radiology 1994; 193:593-595.
124. Hagspiel KD, Neidl KF, Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995; 196: 471-478.
125. Reimer P, Rummeny EJ, Shamsi K, et al. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 1996; 199:177-183.
126. Saini S, Edelman RR, Sharma P, et al. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). AJR 1995; 164:1147-1152.
127. Murakami T, Baron RL, Federle MP, et al. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 1996; 198:567-572.
128. Tavill AS. Hemochromatosis. In: Schiff L, Schiff ER, eds. Diseases of the liver. 7th ed. Philadelphia, Pa: Lippincott, 1993; 669-691.
129. McLaren GD, Muir WA, Kellermeyer RW. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. Crit Rev Clin Lab Sci 1984; 19:205-266.
130. Niederau C, Fischer R, Sonnenberg A, et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313:1256-1262.
131. Siegelman ES, Mitchell DG, Outwater E, Munoz SJ, Rubin R. Idiopathic hemochromatosis: MR imaging findings in cirrhotic and precirrhotic patients. Radiology 1993; 188:637-641.
132. Siegelman ES, Mitchell DG, Semelka RC. Abdominal iron deposition: metabolism, MR findings, and clinical importance. Radiology 1996; 199:13-22.
133. Kane RA, Katz SG. The spectrum of sonographic findings in portal hypertension: subject review and new observations. Radiology 1982; 142:453-458.
134. Nghiem HV, Winter TC III, Mountford MC, et al. Evaluation of the portal venous system before liver transplantation: value of phase-contrast MR angiography. AJR 1995; 164:871-878.
135. Palmer EL, Scott JA, Strauss HW. Abdominal imaging. In: Palmer EL, Scott JA, Strauss HW, eds. Practical nuclear medicine. Philadelphia, Pa: Saunders, 1992; 275-309.
136. Mettler FA Jr, Guiberteau MJ. Gastrointestinal tract. In: Mettler FA Jr, Guiberteau MJ, eds. Essentials of nuclear medicine imaging. 3rd ed. Philadelphia, Pa: Saunders, 1991; 177-207.
137. Thrall JH, Ziessman HA. Hepatobiliary system. In: Thrall JH, Ziessman HA, eds. St Louis, Mo: Mosby-Year Book, 1995; 191-225.
138. Rush C, Stern J. Gallium-67 SPECT imaging in hepatocellular carcinoma. Clin Nucl Med 1988; 11:535-537.
139. Okazumi S, Isono K, Enomoto K, et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J Nucl Med 1992; 33:333-339.
140. Torizuka T, Tamaki N, Inokuma T, et al. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med 1994; 35:1965-1969.
141. Ziessman HA, Thrall JH, Yang PJ, et al. Hepatic arterial perfusion scintigraphy with Tc-99m MAA. Radiology 1984; 152: 167-172.
142. Kudo M, Ikekubo K, Yamamoto K, et al. Distinction between hemangioma of the liver and hepatocellular carcinoma: value of labeled RBC-SPECT scanning. AJR 1989; 152:977-983.